×
About 694 results

ALLMedicine™ Thrombin Time Center

Research & Reviews  343 results

Pre-analytical variables in haemostasis: Findings from the United Kingdom National Exte...
https://doi.org/10.1111/ijlh.13468
International Journal of Laboratory Hematology; Brown L, Jennings I et. al.

Feb 19th, 2021 - Haemolysis is considered one of the major contributors of nonconformities and sample rejection in coagulation testing. Two lyophilized plasmas were distributed to 800 centres registered for prothrombin time (PT), activated partial thromboplastin t...

Changes in levels of coagulation parameters in different trimesters among Chinese pregn...
https://doi.org/10.1002/jcla.23724
Journal of Clinical Laboratory Analysis; Wang W, Long K et. al.

Feb 5th, 2021 - This article is to explore changes in levels of coagulation parameters in different trimesters among healthy pregnant women in China. A total of 760 eligible women were enrolled (first-trimester group: n = 183, second-trimester group: n = 183, thi...

Revisiting the effects of spectral interfering substances in optical end-point coagulat...
https://doi.org/10.1111/ijlh.13465
International Journal of Laboratory Hematology REFERENCES; Seheult JN, Dalenberg D et. al.

Jan 17th, 2021 - Hemolysis, icterus, and lipemia (HIL) are common pre-analytical variables in the clinical laboratory. Understanding their effects on coagulation laboratory results is essential. HIL effects on the prothrombin time (PT), activated partial thrombopl...

Changes in Coagulation During Twin Pregnancies.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7783872
Clinical and Applied Thrombosis/hemostasis : Official Jou... Ren K, Wei Y et. al.

Dec 29th, 2020 - To investigate changes in coagulation during twin pregnancies. Methods: A total of 108 women with twin pregnancies and 442 women with singleton pregnancies were recruited. Coagulation tests, including fibrinogen (Fib), activated partial thrombopla...

Identification and analysis of transepithelial transport properties of casein peptides ...
https://doi.org/10.1016/j.foodres.2020.109764
Food Research International (Ottawa, Ont.); Tu M, Liu H et. al.

Dec 9th, 2020 - Casein is an excellent source for producing anticoagulant and angiotensin I-converting enzyme inhibitory (ACEI) peptides. Here, the anticoagulant and ACEI activities of the casein hydrolysate produced by in vitro simulated gastrointestinal (GI) di...

see more →

Clinicaltrials.gov  347 results

Pre-analytical variables in haemostasis: Findings from the United Kingdom National Exte...
https://doi.org/10.1111/ijlh.13468
International Journal of Laboratory Hematology; Brown L, Jennings I et. al.

Feb 19th, 2021 - Haemolysis is considered one of the major contributors of nonconformities and sample rejection in coagulation testing. Two lyophilized plasmas were distributed to 800 centres registered for prothrombin time (PT), activated partial thromboplastin t...

Changes in levels of coagulation parameters in different trimesters among Chinese pregn...
https://doi.org/10.1002/jcla.23724
Journal of Clinical Laboratory Analysis; Wang W, Long K et. al.

Feb 5th, 2021 - This article is to explore changes in levels of coagulation parameters in different trimesters among healthy pregnant women in China. A total of 760 eligible women were enrolled (first-trimester group: n = 183, second-trimester group: n = 183, thi...

Revisiting the effects of spectral interfering substances in optical end-point coagulat...
https://doi.org/10.1111/ijlh.13465
International Journal of Laboratory Hematology REFERENCES; Seheult JN, Dalenberg D et. al.

Jan 17th, 2021 - Hemolysis, icterus, and lipemia (HIL) are common pre-analytical variables in the clinical laboratory. Understanding their effects on coagulation laboratory results is essential. HIL effects on the prothrombin time (PT), activated partial thrombopl...

Changes in Coagulation During Twin Pregnancies.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7783872
Clinical and Applied Thrombosis/hemostasis : Official Jou... Ren K, Wei Y et. al.

Dec 29th, 2020 - To investigate changes in coagulation during twin pregnancies. Methods: A total of 108 women with twin pregnancies and 442 women with singleton pregnancies were recruited. Coagulation tests, including fibrinogen (Fib), activated partial thrombopla...

Identification and analysis of transepithelial transport properties of casein peptides ...
https://doi.org/10.1016/j.foodres.2020.109764
Food Research International (Ottawa, Ont.); Tu M, Liu H et. al.

Dec 9th, 2020 - Casein is an excellent source for producing anticoagulant and angiotensin I-converting enzyme inhibitory (ACEI) peptides. Here, the anticoagulant and ACEI activities of the casein hydrolysate produced by in vitro simulated gastrointestinal (GI) di...

see more →

News  4 results

Drug can reverse anticoagulant effect in emergencies
https://www.mdedge.com/hematology-oncology/article/188314/thrombosis/drug-can-reverse-anticoagulant-effect-emergencies
HT Staff

Apr 7th, 2016 - Team performing surgery Photo by Piotr Bodzek CHICAGO—Updated results from the RE-VERSE AD trial suggest idarucizumab, a humanized antibody fragment, can reverse the anticoagulant effect of dabigatran in emergency settings. In this ongoing phase 3.

Drug reverses anticoagulant effect of dabigatran
https://www.mdedge.com/hematology-oncology/article/188650/thrombosis/drug-reverses-anticoagulant-effect-dabigatran
HT Staff

Jun 24th, 2015 - TORONTO—Interim results of a phase 3 study suggest idarucizumab, a humanized antibody fragment, can reverse the anticoagulant effect of dabigatran in real-world situations. In the RE-VERSE AD trial, idarucizumab normalized diluted thrombin time (d.

NOAC Antidote Promising in Phase III Trial
https://www.medpagetoday.com/cardiology/venousthrombosis/52239

Jun 22nd, 2015 - Idarucizumab restored clotting in most patients on the new oral anticoagulant (NOAC) dabigatran (Pradaxa) who had serious bleeding or required urgent surgery, according to interim results of the phase III RE-VERSE AD trial. The median maximum perc...

Bivalirudin: A Direct Thrombin Inhibitor for Percutaneous Transluminal Coronary Angioplasty
https://www.medscape.com/viewarticle/441285_6

Monitoring Bivalirudin appears to produce a linear and dose-dependent increase in several laboratory parameters, including the ACT, aPTT, prothrombin time, and thrombin time.[21] In PCI procedures, in which immediate laboratory results are necessa...

see more →